Oxbridge Re Holdings Equity Warrant (OXBRW) had the highest return between December 1, 2019 and December 9, 2019 by a US stock, returning 298.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Oxbridge Re Holdings Equity Warrant (OXBRW) | 12/1/2019 - 12/9/2019 | 298.23% |
iBio, Inc Common Stock (IBIO) | 12/1/2019 - 12/9/2019 | 132.24% |
Mawson Infrastructure (MIGI) | 12/1/2019 - 12/9/2019 | 115.63% |
DarioHealth (DRIO) | 12/1/2019 - 12/9/2019 | 103.93% |
Aurinia Pharmaceuticals (AUPH) | 12/1/2019 - 12/9/2019 | 95.3% |
Kodiak Sciences (KOD) | 12/1/2019 - 12/9/2019 | 93.97% |
Lexicon Pharmaceuticals (LXRX) | 12/1/2019 - 12/9/2019 | 87.92% |
Shineco (SISI) | 12/1/2019 - 12/9/2019 | 81% |
Nisun International Enterprise Development (NISN) | 12/1/2019 - 12/9/2019 | 80.17% |
Red Cat (RCAT) | 12/1/2019 - 12/9/2019 | 78.55% |
Obsidian Energy (OBE) | 12/1/2019 - 12/9/2019 | 71.43% |
XBiotech (XBIT) | 12/1/2019 - 12/9/2019 | 67.38% |
Iterum Therapeutics (ITRM) | 12/1/2019 - 12/9/2019 | 62.45% |
Traws Pharma (TRAW) | 12/1/2019 - 12/9/2019 | 60.76% |
Gryphon Digital Mining (GRYP) | 12/1/2019 - 12/9/2019 | 57.2% |
Comstock Mining (LODE) | 12/1/2019 - 12/9/2019 | 51.06% |
GlucoTrack (GCTK) | 12/1/2019 - 12/9/2019 | 50.57% |
Sobr Safe (SOBR) | 12/1/2019 - 12/9/2019 | 50.38% |
PG&E (PCG) | 12/1/2019 - 12/9/2019 | 48.67% |
Matinas BioPharma (MTNB) | 12/1/2019 - 12/9/2019 | 46.4% |
Cibus Global LLC (CBUS) | 12/1/2019 - 12/9/2019 | 46.4% |
Arbutus Biopharma (ABUS) | 12/1/2019 - 12/9/2019 | 40.48% |
Titan Pharmaceuticals (TTNP) | 12/1/2019 - 12/9/2019 | 39.38% |
Genesco (GCO) | 12/1/2019 - 12/9/2019 | 37.27% |
Lands’ End (LE) | 12/1/2019 - 12/9/2019 | 36.73% |
